Search research articles
Contact Us
Filters
Showing results (11-20 of 217) with videos related to
Page
of 22
Sort By:
Annals of the New York Academy of Sciences
|
July 23, 2005
Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy
Reiko Inagi, Masaomi Nangaku, Toshio Miyata
International Journal of Clinical Oncology
|
April 11, 2025
Evaluation of drug lag and drug loss in Japan: participation in global phase III oncology trials
Kaname Shiga, Taro Shibata, Toshio Miyata
Annals of the New York Academy of Sciences
|
July 23, 2005
From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy
Toshio Miyata, Makoto Yamamoto, Yuko Izuhara
Regenerative Medicine
|
March 1, 2017
Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan
Kiyoshi Okada, Toshio Miyata, Yoshiki Sawa
Biomedical Journal
|
July 20, 2025
PAI-1 is a common driver of aging and diverse diseases
Alireza Khoddam, Toshio Miyata, Douglas Vaughan
Nature Reviews. Nephrology
|
December 17, 2009
Diabetic nephropathy: a disorder of oxygen metabolism?
Toshio Miyata, Charles van Ypersele de Strihou
Current Genomics
|
July 23, 2008
Megsin gene: its genomic analysis, pathobiological functions, and therapeutic perspectives
Toshio Miyata, Ming Li, Xueqing Yu, et al.
Clinical and Experimental Nephrology
|
October 31, 2003
Mesangial cell-predominant functional gene, megsin
Reiko Inagi, Masaomi Nangaku, Toshio Miyata, et al.
Medical Molecular Morphology
|
June 10, 2005
Serpinopathy and endoplasmic reticulum stress
Toshio Miyata, Reiko Inagi, Satoshi Sugiyama, et al.
Advances in Experimental Medicine and Biology
|
February 14, 2008
Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation
Masaomi Nangaku, Reiko Inagi, Toshio Miyata, et al.
Page
of 22
Search research articles
Search
Showing results (11-20 of 217) with videos related to
Sort By:
Page
of 22
Annals of the New York Academy of Sciences
|
July 23, 2005
Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy
Reiko Inagi, Masaomi Nangaku, Toshio Miyata
International Journal of Clinical Oncology
|
April 11, 2025
Evaluation of drug lag and drug loss in Japan: participation in global phase III oncology trials
Kaname Shiga, Taro Shibata, Toshio Miyata
Annals of the New York Academy of Sciences
|
July 23, 2005
From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy
Toshio Miyata, Makoto Yamamoto, Yuko Izuhara
Regenerative Medicine
|
March 1, 2017
Insurance systems and reimbursement concerning research and development of regenerative medicine in Japan
Kiyoshi Okada, Toshio Miyata, Yoshiki Sawa
Biomedical Journal
|
July 20, 2025
PAI-1 is a common driver of aging and diverse diseases
Alireza Khoddam, Toshio Miyata, Douglas Vaughan
Nature Reviews. Nephrology
|
December 17, 2009
Diabetic nephropathy: a disorder of oxygen metabolism?
Toshio Miyata, Charles van Ypersele de Strihou
Current Genomics
|
July 23, 2008
Megsin gene: its genomic analysis, pathobiological functions, and therapeutic perspectives
Toshio Miyata, Ming Li, Xueqing Yu, et al.
Clinical and Experimental Nephrology
|
October 31, 2003
Mesangial cell-predominant functional gene, megsin
Reiko Inagi, Masaomi Nangaku, Toshio Miyata, et al.
Medical Molecular Morphology
|
June 10, 2005
Serpinopathy and endoplasmic reticulum stress
Toshio Miyata, Reiko Inagi, Satoshi Sugiyama, et al.
Advances in Experimental Medicine and Biology
|
February 14, 2008
Angiotensin-induced hypoxia in the kidney: functional and structural changes of the renal circulation
Masaomi Nangaku, Reiko Inagi, Toshio Miyata, et al.
Page
of 22